Preferred Label : xarelto;

UMLS semantic type : T109 - Organic Chemical; T121 - Pharmacologic Substance;

Is substance : O;

Details


Main resources

You can consult :


https://www.has-sante.fr/jcms/p_3287831/fr/xarelto-1-mg/ml-rivaroxaban
2021
France
evaluation of the transparency committee
rivaroxaban
Rivaroxaban
xarelto

---
https://www.has-sante.fr/jcms/p_3114491/fr/xarelto
2019
false
false
false
France
insurance, health, reimbursement
treatment outcome
administration, oral
Factor Xa Inhibitors
drug therapy, combination
aspirin
adult
Atherothrombosis
acute coronary syndrome
coronary disease
peripheral arterial disease
Atherothrombosis prophylaxis
rivaroxaban
Clopidogrel
ticlopidine
thrombosis
evaluation of the transparency committee
xarelto
Rivaroxaban
Rivaroxaban

---
https://www.has-sante.fr/portail/jcms/c_2826828/fr/xarelto
2018
false
false
false
false
France
French
evaluation of the transparency committee
xarelto
Rivaroxaban

---
https://www.has-sante.fr/portail/jcms/c_2826828/fr/xarelto-15-mg-20-mg-fanv
2018
false
false
false
false
France
French
evaluation of the transparency committee
xarelto
Rivaroxaban

---
https://www.has-sante.fr/portail/jcms/c_2888447/fr/xarelto
2018
false
false
false
France
recurrence
pulmonary embolism
venous thrombosis
administration, oral
Factor Xa Inhibitors
deep vein thrombosis
treatment outcome
deep vein thrombosis
pulmonary embolism
rivaroxaban
evaluation of the transparency committee
xarelto
Rivaroxaban
venous thrombosis

---
Nous contacter.
30/04/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.